[Experience with Vadilex in the treatment of cerebral vascular insufficiency].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000605:Amino Alcohols / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000605:Amino Alcohols; D010880:Piperidines; D014665:Vasodilator Agents
Expérience du Vadilex dans le traitement des insuffisances vasculaires cérébrales.